Regulatory Consulting Services

RTI serves as a full-service regulatory partner, bridging the gap between innovative science and clinical development readiness. By combining regulatory experience with deep scientific expertise, RTI provides integrated support designed to anticipate regulatory challenges, strengthen development programs, and help clients efficiently advance toward first-in-human studies and beyond.  

We provide clients with a regulatory roadmap that spans the development lifecycle, aligning scientific, operational, and regulatory activities with key milestones and FDA expectations. Our senior/expert regulatory staff is prepared to support your journey from early discovery through trials and beyond.  

As development programs evolve, this integrated framework provides clients with experienced regulatory support at critical decision points, helping them manage risk, maintain momentum, and build a stronger foundation for successful clinical development and eventual commercialization. 

RTI’s multidisciplinary regulatory team includes experts with decades of experience across pharma, contract research organizations (CROs), and the FDA. Our deep bench includes specialized expertise in areas including, but not limited to, infectious disease, cardiovascular, pulmonary, hematologic, and oncology. 

Unlike large commercial CROs where small biotech firms face rotating junior staff and de-prioritization, RTI provides personalized, senior-level attention. Conversely, while academic institutions often focus on publishing research, RTI focuses exclusively on market-ready commercialization and reaching regulatory milestones. 

RTI combines the scientific depth associated with a research institute with the development focus and regulatory expertise needed to advance medical products. Small and emerging biotech companies receive personalized, senior-level attention from experts focused on moving programs through critical regulatory milestones and toward commercialization. 

• Deep Drug Development Experience: Our multidisciplinary team brings extensive experience in regulatory strategy and medical product development, with longstanding relationships across government, industry, nonprofit, and academic organizations. We apply this breadth of experience to help clients anticipate challenges and efficiently advance promising products through development. 
• Proven IND Track Record: We maintain a high success rate in securing IND clearances by identifying and mitigating risks for clinical holds well before the submission window. 
• Client-Aligned Partnership: As an independent, nonprofit research institute, RTI provides objective scientific and regulatory support tailored to each client's technology and development goals. Our role is to complement the client's expertise and help advance its product through key regulatory and development milestones.